Clinical trial

Probiotic Supplementation and Pancreatic β-Cell Function in Type 2 Diabetes

NCT05765292

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-03-01

PhaseNA

Study timeline

Study start (actual)2021-03-01Date precision: day

Registry last updated2023-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2 Diabetesunresolved

Obesityunresolved

Insulin Resistanceunresolved

Obesity, Abdominalunresolved

Interventions

ProbioticDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Bogomolets National Medical Universitylead sponsor

Taras Shevchenko National University of Kyivcollaborator

Danylo Halytsky Lviv National Medical Universitycollaborator

Kyiv City Clinical Endocrinology Centercollaborator

Mapped research locations

KyivUkraine3 LvivUkraine1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05765292 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.